ROCO
4744
Market cap42mUSD
Nov 12, Last price
25.80TWD
Name
CVC Technologies Inc
Chart & Performance
P/E
32.50
P/S
1.04
EPS
0.79
Div Yield, %
0.39%
Shrs. gr., 5y
3.26%
Rev. gr., 5y
2.79%
Revenues
1.29b
+14.24%
Net income
41m
+187.62%
CFO
214m
P
Dividend
Jul 16, 20240.1 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CVC Technologies Inc. manufactures and sells various types of pharmaceutical packaging machines worldwide. The company offer tablet counting machines, such as bottle unscrambler and air rinser; tablet/capsule counter and filler; desiccant inserter; cotton/foam inserter; capper which includes chuck, rotary, vial, in-line, and vibratory press capper; induction cap sealer; shrink bundler and tunnel; intermittent cartoner; and track and trace machines. It also provides labeling machines, including top/bottom/side labelers, wrap-around labelers, front and back labelers, leaflet topserters, shrink sleeve applicators, and labeler inspection systems; liquid and powder filling machines, such as bottle unscrambler and air rinsers, liquid filler and cappers, capper machines, induction capsealers, labeling machines, and cartoner/shrink machines; encapsulation machines; auxiliary equipment, including jet masters, capsule printing machines, paste making systems, gelatin melting tanks, medicine preparation systems, drying systems, gelatin reclaim systems, and capsule inspection machines; and aluminum foil sealing machines, as well as semi-auto tablet/capsule counter. In addition, it offers packaging line design, factory acceptance testing, technical phone support, and field service and preventative maintenance services, as well as installation, startup, and training services. The company was founded in 1979 and is headquartered in Taichung, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||